Cancer biomarkers

被引:567
作者
Henry, N. Lynn [1 ]
Hayes, Daniel F. [1 ]
机构
[1] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA
关键词
Biomarker; Cancer; Tumor marker; CLINICAL-PRACTICE GUIDELINE; AMERICAN-SOCIETY; BREAST-CANCER; TUMOR-MARKERS; ADJUVANT CHEMOTHERAPY; MOLECULAR MARKERS; 2006; UPDATE; RECOMMENDATIONS; SERUM; BRCA1;
D O I
10.1016/j.molonc.2012.01.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Biomarkers have many potential applications in oncology, including risk assessment, screening, differential diagnosis, determination of prognosis, prediction of response to treatment, and monitoring of progression of disease. Because of the critical role that biomarkers play at all stages of disease, it is important that they undergo rigorous evaluation, including analytical validation, clinical validation, and assessment of clinical utility, prior to incorporation into routine clinical care. In this review we address key steps in the development of biomarkers, including ways to avoid introducing bias and guidelines to follow when reporting results of biomarker studies. (C) 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:140 / 146
页数:7
相关论文
共 41 条
[1]   American Society of Clinical Oncology Provisional Clinical Opinion: Testing for KRAS Gene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy [J].
Allegra, Carmen J. ;
Jessup, J. Milburn ;
Somerfield, Mark R. ;
Hamilton, Stanley R. ;
Hammond, Elizabeth H. ;
Hayes, Daniel F. ;
McAllister, Pamela K. ;
Morton, Roscoe F. ;
Schilsky, Richard L. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (12) :2091-2096
[2]   Commentary: Hormone Receptor Testing in Breast Cancer: A Distress Signal from Canada [J].
Allred, D. Craig .
ONCOLOGIST, 2008, 13 (11) :1134-1136
[3]   Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments [J].
Baggerly, KA ;
Morris, JS ;
Coombes, KR .
BIOINFORMATICS, 2004, 20 (05) :777-U710
[4]  
Bang YJ, 2010, LANCET, V376, P1302
[5]   Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative [J].
Bossuyt, PM ;
Reitsma, JB ;
Bruns, DE ;
Gatsonis, CA ;
Glasziou, PP ;
Irwig, LM ;
Lijmer, JG ;
Moher, D ;
Rennie, D ;
de Vet, HCW .
ANNALS OF INTERNAL MEDICINE, 2003, 138 (01) :40-44
[6]   American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Chemotherapy Sensitivity and Resistance Assays [J].
Burstein, Harold J. ;
Mangu, Pamela B. ;
Somerfield, Mark R. ;
Schrag, Deborah ;
Samson, David ;
Holt, Lawrence ;
Zelman, Debra ;
Ajani, Jaffer A. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (24) :3328-3330
[7]   Invasive Breast Cancer [J].
Carlson, Robert W. ;
Allred, Craig ;
Anderson, Benjamin O. ;
Burstein, Harold J. ;
Carter, W. Bradford ;
Edge, Stephen B. ;
Erban, John K. ;
Farrar, William B. ;
Forero, Andres ;
Giordano, Sharon Hermes ;
Goldstein, Lori J. ;
Gradishar, William J. ;
Hayes, Daniel F. ;
Hudis, Clifford A. ;
Ljung, Britt-Marie ;
Mankoff, David A. ;
Marcom, P. Kelly ;
Mayer, Ingrid A. ;
McCormick, Beryl ;
Pierce, Lori J. ;
Reed, Elizabeth C. ;
Sachdev, Jasgit ;
Smith, Mary Lou ;
Somlo, George ;
Ward, John H. ;
Wolff, Antonio C. ;
Zellars, Richard .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2011, 9 (02) :136-222
[8]   Association of high Gli1 expression with poor survival in head and neck cancer patients treated with radiation therapy (RTOG 9003) [J].
Chung, C. H. ;
Dignam, J. ;
Hammond, M. E. ;
Magliocco, A. M. ;
Jordon, R. ;
Trotti, A. ;
Spencer, S. ;
Cooper, J. S. ;
Le, Q. ;
Ang, K. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[9]   Circulating tumor cells, disease progression, and survival in metastatic breast cancer [J].
Cristofanilli, M ;
Budd, GT ;
Ellis, MJ ;
Stopeck, A ;
Matera, J ;
Miller, MC ;
Reuben, JM ;
Doyle, GV ;
Allard, WJ ;
Terstappen, LWMM ;
Hayes, DF .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (08) :781-791
[10]   Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials [J].
Davies, C. ;
Godwin, J. ;
Gray, R. ;
Clarke, M. ;
Darby, S. ;
McGale, P. ;
Wang, Y. C. ;
Peto, R. ;
Pan, H. C. ;
Cutter, D. ;
Taylor, C. ;
Ingle, J. .
LANCET, 2011, 378 (9793) :771-784